Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

US Patent 6780855 · Granted Aug 24, 2004

Estimated economic value: $876,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Urinary pumping device2025
Polychloroprene-based contact adhesives containing ethylene-vinyl acetate copoly2024
Methods and means for genetic alteration of genomes utilizing designer DNA recom2023
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides2023
2-phenylpyrimidine-4-carboxamides as AHR inhibitors2022
Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides2022
Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors2022
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists2022
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides2021
Low temperature cross linkable polychloroprene compositions2021
Compounds for treatment of diseases related to DUX4 expression2021
Fused imidazoles as mIDH1 inhibitors2021